Advanced search
Publication Cover
Gynecological Endocrinology Volume 29, 2013 - Issue 3
Submit an article Journal homepage
131
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy

Rong ChenDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, P. R. of ChinaCorrespondence[email protected]
,
Huimei ZhouDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, P. R. of China
&
Yiwen ZhangDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, P. R. of China
Pages 216-218 | Received 18 Mar 2012, Accepted 13 Sep 2012, Published online: 16 Nov 2012

References

  • Lian Lijuan, Jin Ying. Ovary cyst or adnexal cyst among postmenopausal women. In: Lian lijuan, editor. Lin qiaozhi Gynecology oncology. 4th ed. Beijing: People’s Medical Publishing House; 2006. pp 926–929.
  • Studee DW, Pinus A. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;4:302–320.
  • Annaiah TK, Reynolds SF, Lopez C. Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? J Obstet Gynaecol 2012;32:267–270.
  • Riman T, Nilsson S, Persson IR. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004;83:783–795.
  • Garg PP, Kerlikowske K, Subak L, Grady D. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998;92:472–479.
  • Zhou B, Sun Q, Cong R, Gu H, Tang N, Yang L, Wang B. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. Gynecol Oncol 2008;108:641–651.
  • Coughlin SS, Giustozzi A, Smith SJ, Lee NC. A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer. J Clin Epidemiol 2000;53:367–375.
  • Mills PK, Riordan DG, Cress RD, Goldsmith DF. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk. Cancer Detect Prev 2005;29:124–132.
  • Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;16:2548–2556.
  • Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE. A prospective study of postmenopausal hormone use and ovarian cancer risk. Br J Cancer 2007;96:151–156.
  • Bell DA, Scully RE. Benign and borderline clear cell adenofibromas of the ovary. Cancer 1985;56:2922–2931.
  • Tavassoli FA, Devilee P (eds). World Health Organization classification of tumours. In: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003; pp 218–228.
  • Pasaoglu O, Ciftçi E, Tel N, Ozalp S, Acikalin MF. Benign clear cell adenofibroma of the ovary. A case report with literature review. Gynecol Obstet Invest 2007;64:36–39.
  • Roth LM, Langley FA, Fox H, Wheeler JE, Czernobilsky B. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 1984;53:1156–1163.
  • Kao GF, Norris HJ. Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types. Obstet Gynecol 1979;54:729–736.
  • Zhao C, Wu LS, Barner R. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer 2011;2:94–106.
  • Jia Wei, Lu Tiancai, Zheng Xingzhen, Tao Lin, Zheng Yuqin. One case of benign clear cell adenofibroma of the ovary. Diag Pathol 2007;14:155.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.